Lv4
710 积分 2021-04-27 加入
Tyrosine phosphatase SHP-2 mediates C-type lectin receptor–induced activation of the kinase Syk and anti-fungal TH17 responses
17小时前
待确认
Pyrrolidine-3-carboxylic Acids as Endothelin Antagonists. 5. Highly Selective, Potent, and Orally Active ETA Antagonists
13天前
已完结
OP0095 Efficacy and safety of deucravacitinib up to week 52 from POETYK PsA-2: a multicenter, randomized, double-blind, placebo-controlled, phase 3 study in patients with psoriatic arthritis
2个月前
已关闭
Correction to: Drug survival and effectiveness of ustekinumab in patients with psoriatic arthritis. Real-life data from the biologic Apulian registry (BIOPURE)
2个月前
已完结
Modulation of Interleukin‐23 Signaling With Guselkumab in Biologic‐Naive Patients Versus Tumor Necrosis Factor Inhibitor–Inadequate Responders With Active Psoriatic Arthritis
2个月前
已完结
Advanced Combination Therapy in Inflammatory Bowel Disease: What Does the Future Hold?
2个月前
已完结
Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome: an update
3个月前
已完结
Strategies for targeting cytokines in inflammatory bowel disease
3个月前
已完结
Dual Therapy in Inflammatory Bowel Disease
3个月前
已完结
Safety and pharmacokinetics of SOR102, an oral bispecific inhibitor of TNF and interleukin-23 in healthy participants and patients with ulcerative colitis: a first-in-human, double-blind, randomised, placebo-controlled, phase 1 trial
3个月前
已完结
皖公网安备34019202002308
